TX MPJE FINAL PAPER CORE QUESTIONS AND
ANSWERS SURE A+
✔✔What specific prescriptions and nonprescriptions drugs are exempt from the Poison
Prevention Packaging Act? - ✔✔1. OC , conjugated estrogens, and northdrone acetate
in manufactures dispenser package
2. Medroxyprogesterone acetate tablets
3. SL NG and SL/chewable isosorbide *dinitrate of 10mg* or less
4. ASA and APAP in effervescent tablets or granulates
5. K supplements in unit dose packaging
6. Sodium fluoride containing no more than *264 mg* of sodium fluoride per package
7. Anhydrous cholestyramine and colestipol packets
8. Erythromycin ethylsuccinate *granuales* for oral suspension and oral suspension in
packages containing not more than *8 gm* of erythromycin or *tablets* counting no
more than *16gm*
9. Prednisone no more than 105 mg/package
, 10. Methyprednsisolone no more than 84 mg/package (Medrol dose pack is ex)
11. Mebendazone no more than 600 mg/package
12. Betamethasone tabs no more than 12.6 mg/package
13. aerosol containers for inhalation (proair ex)
14. Pancrelipase prepraptions
15. Sucrose preparations
16. Hormone replacement therapy
✔✔PPI are required for? - ✔✔OC
Estrogen products
*no longer required for progesterones*
✔✔T/F: FDA has legal authority to order recalls for medical devices, foods (including
dietary supplements), and drugs? - ✔✔False: only medical devices
✔✔Poison Prevention Packaging Act is administered by who? - ✔✔Consumer Product
Safety Commision
*NOT FDA*
✔✔The Federal Controlled Substance Act is Administered by who? - ✔✔DEA
TCSA
DPS
TSBP
✔✔DEA allows narcotics to be compounded without registering as a manufacturer if the
final concentration is not greater than what? - ✔✔20%
✔✔TX allows APRN and PA to prescribe CIII-CV for how many days max? - ✔✔90 days
(includes refills: ex 30 day supply plus 2 refills)
✔✔What can't be changed on a CII - ✔✔Name of Patient
Name of Prescriber
Drug name
Date written
ANSWERS SURE A+
✔✔What specific prescriptions and nonprescriptions drugs are exempt from the Poison
Prevention Packaging Act? - ✔✔1. OC , conjugated estrogens, and northdrone acetate
in manufactures dispenser package
2. Medroxyprogesterone acetate tablets
3. SL NG and SL/chewable isosorbide *dinitrate of 10mg* or less
4. ASA and APAP in effervescent tablets or granulates
5. K supplements in unit dose packaging
6. Sodium fluoride containing no more than *264 mg* of sodium fluoride per package
7. Anhydrous cholestyramine and colestipol packets
8. Erythromycin ethylsuccinate *granuales* for oral suspension and oral suspension in
packages containing not more than *8 gm* of erythromycin or *tablets* counting no
more than *16gm*
9. Prednisone no more than 105 mg/package
, 10. Methyprednsisolone no more than 84 mg/package (Medrol dose pack is ex)
11. Mebendazone no more than 600 mg/package
12. Betamethasone tabs no more than 12.6 mg/package
13. aerosol containers for inhalation (proair ex)
14. Pancrelipase prepraptions
15. Sucrose preparations
16. Hormone replacement therapy
✔✔PPI are required for? - ✔✔OC
Estrogen products
*no longer required for progesterones*
✔✔T/F: FDA has legal authority to order recalls for medical devices, foods (including
dietary supplements), and drugs? - ✔✔False: only medical devices
✔✔Poison Prevention Packaging Act is administered by who? - ✔✔Consumer Product
Safety Commision
*NOT FDA*
✔✔The Federal Controlled Substance Act is Administered by who? - ✔✔DEA
TCSA
DPS
TSBP
✔✔DEA allows narcotics to be compounded without registering as a manufacturer if the
final concentration is not greater than what? - ✔✔20%
✔✔TX allows APRN and PA to prescribe CIII-CV for how many days max? - ✔✔90 days
(includes refills: ex 30 day supply plus 2 refills)
✔✔What can't be changed on a CII - ✔✔Name of Patient
Name of Prescriber
Drug name
Date written
